A 28-day clinical trial of aerosolized hyaluronan in alpha-1 antiprotease deficiency COPD using desmosine as a surrogate marker for drug efficacy.
A previous 2-week clinical trial of aerosolized hyaluronan (HA) in COPD showed a rapid reduction...
Read More